Log In
BCIQ
Print this Print this
 

Byvalson, Nebivolol/valsartan

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionFixed-dose combination of nebivolol, an adrenergic receptor beta 1 (ADRB1) antagonist, and valsartan, a small molecule angiotensin II receptor (type AT1) antagonist
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentApproved
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today